Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Meta’s co-founder says being a CEO for 13 years was exhausting: I ‘put on this face day after day’
“I’d intended to be more of a independent or head of engineering,” Dustin Moskovitz, Asana’s co-founder and chairman said about…
Trump pauses higher tariffs for 90 days but escalates China trade war
Trump has said he is authorising a universal “lowered reciprocal tariff of 10%” for most countries, except China, while tariff…
DotaMath: Advancing LLMs’ Mathematical Reasoning Through Decomposition and Self-Correction
Large language models (LLMs) have significantly advanced various natural language processing tasks, but they still face substantial challenges in complex…